Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
PHASE3CompletedINTERVENTIONAL
Enrollment
74
Participants
Timeline
Start Date
July 31, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
Conditions
PoliomyelitisPolio
Interventions
BIOLOGICAL
Inactive Poliovirus Vaccine
0.5 mL, Subcutaneous
Trial Locations (2)
Unknown
Fukui-shi
Sapporo
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT01389687 - Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan | Biotech Hunter | Biotech Hunter